| Bombardier’s Global 8000 Aircraft Makes its South American Debut at the Catarina Aviation Show in Brazil, Joins the Exquisite Global 6500 and Challenger 3500 on site |
Globe Newswire |
05/07 |
07:30 |
| Pit Launches with $16 Million Led by Andreessen Horowitz to Bring AI-Native Software to Enterprise Operations |
Globe Newswire |
05/07 |
07:30 |
| Palvella Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/07 |
07:30 |
| Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/07 |
07:30 |
| MACOM Reports Fiscal Second Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:30 |
| Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates |
Globe Newswire |
05/07 |
07:30 |
| Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic |
Globe Newswire |
05/07 |
07:30 |
| Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress |
Globe Newswire |
05/07 |
07:30 |
| One Bullion Reports Gravity-Finish Assay Results at Vumba Project, Including 30.8 g/t Au, and Receives EIA Approval for Maitengwe Project |
Globe Newswire |
05/07 |
07:30 |
| BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study |
Globe Newswire |
05/07 |
07:30 |
| Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026 |
Globe Newswire |
05/07 |
07:30 |
| Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:30 |
| MasterCraft Boat Holdings, Inc. Reports Fiscal 2026 Third Quarter Results |
Globe Newswire |
05/07 |
07:30 |
| Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026 |
Globe Newswire |
05/07 |
07:25 |
| MarketWise Reports Net Revenue of $77.0 Million and Net Loss of $0.6 Million for First Quarter 2026; Q1 Billings Increase 15% YoY; Announced Quarterly Regular and Special Dividends totaling $0.45 per Class A share; Affirms FY 2026 Guidance of Billings of $300 Million and CFFO of $50 Million; Board Authorizes New $50M Share Buyback Program |
Globe Newswire |
05/07 |
07:22 |
| Entrada Therapeutics Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:10 |
| TerrAscend Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:10 |
| Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates |
Globe Newswire |
05/07 |
07:05 |
| GPGI Reports First Quarter 2026 Results |
Globe Newswire |
05/07 |
07:05 |
| Appian Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:05 |
| Resolute Holdings Reports First Quarter 2026 Results |
Globe Newswire |
05/07 |
07:05 |
| Xometry Reports Record First Quarter 2026 Results |
Globe Newswire |
05/07 |
07:05 |
| Chicago Atlantic Real Estate Finance Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
07:00 |
| Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 |
Globe Newswire |
05/07 |
07:00 |
| Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study |
Globe Newswire |
05/07 |
07:00 |
